Flatiron Health expands AI-powered breast cancer and NSCLC data to UK, Germany and Japan
Roche unit Flatiron Health launched AI-extracted breast cancer and NSCLC real-world datasets covering the UK, Germany and Japan. The offering roughly doubles patient coverage across the two tumor types and geographies compared with prior data offerings.
1. New datasets launched
Flatiron Health launched AI-extracted breast cancer and non-small cell lung cancer (NSCLC) real-world “Panoramic” datasets covering the UK, Germany and Japan. The expansion follows its multinational prostate cancer dataset launch in January 2026.
2. Patient coverage expands
The new datasets use a common data model aligned with Flatiron’s US breast cancer and NSCLC datasets, which span nearly 1.5 million patients. Flatiron said the multinational offering roughly doubles patient coverage compared with prior data offerings across the two tumor types and geographies.
